Company Description
WORK Medical Technology Group LTD, together with its subsidiaries, manufactures and sells medical consumables in the People’s Republic of China and internationally.
The company offers disposable medical devices, such as medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half mask; and visualized prostatic dilatation catheters.
It also exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania.
WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
| Country | China |
| Founded | 2002 |
| IPO Date | Aug 23, 2024 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 229 |
| CEO | Shuang Wu |
Contact Details
Address: No. 2 Tonghuinan Road, Floor 23 Hangzhou City China | |
| Phone | 86 571 8261 3568 |
| Website | hzsy120.com |
Stock Details
| Ticker Symbol | WOK |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001929783 |
| CUSIP Number | G9767H109 |
| ISIN Number | KYG9767H1092 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Shuang Wu | Chairman and Chief Executive Officer |
| Ningfang Liang | Chief Financial Officer |
| Baiming Yu | Chief Operating Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 22, 2025 | 6-K | Report of foreign issuer |
| May 22, 2025 | 424B4 | Prospectus |
| May 20, 2025 | EFFECT | Notice of Effectiveness |
| Apr 29, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Apr 11, 2025 | 6-K | Report of foreign issuer |
| Apr 9, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Mar 5, 2025 | 6-K | Report of foreign issuer |
| Feb 20, 2025 | SCHEDULE 13G | Filing |
| Feb 14, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Feb 7, 2025 | 6-K | Report of foreign issuer |